MLchartDataset catalogue

Etodolac

Term · Oncology and biomedicine · MLC-T-ONC-013463

A pyranocarboxylic acid and non-steroidal anti-inflammatory drug (NSAID) with antipyretic and analgesic activities. Etodolac inhibits the activity of cyclooxygenase I and II, thereby preventing the formation of prostaglandin which is involved in the induction of pain, fever, and inflammation. It also inhibits platelet aggregation by blocking platelet cyclooxygenase and the subsequent formation of thromboxane A2.

Table 1. Record
IdentifierMLC-T-ONC-013463
FieldOncology and biomedicine
SynonymsEtodolic Acid; Ultradol
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-013463",
  "term": "Etodolac",
  "field": "Oncology and biomedicine",
  "definition": "A pyranocarboxylic acid and non-steroidal anti-inflammatory drug (NSAID) with antipyretic and analgesic activities. Etodolac inhibits the activity of cyclooxygenase I and II, thereby preventing the formation of prostaglandin which is involved in the induction of pain, fever, and inflammation. It also inhibits platelet aggregation by blocking platelet cyclooxygenase and the subsequent formation of thromboxane A2.",
  "synonyms": [
    "Etodolic Acid",
    "Ultradol"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/etodolac/"
}

Record 6,977 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.